NCT00030095View on ClinicalTrials.gov

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2001

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

2-methoxyestradiol

Trial Locations (2)

20892

NCI - Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00030095 - 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter